ArticleTherapeutic advances in medical oncology2026
Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failure.
Moonki Hong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.